Home respiratory muscle training in patients with chronic obstructive pulmonary disease

Battaglia, Elvia and Fulgenzi, Alessandro and Bernucci, Stefano and Giardini, Mario E. and Ferrero, Maria E. (2006) Home respiratory muscle training in patients with chronic obstructive pulmonary disease. Respirology, 11 (6). pp. 799-804. (https://doi.org/10.1111/j.1440-1843.2006.00951.x)

[thumbnail of Battaglia-etal-Respirology-2006-Home-respiratory-muscle-training-in-patients-with-chronic-obstructive]
Preview
 Text. Filename: Battaglia_etal_Respirology_2006_Home_respiratory_muscle_training_in_patients_with_chronic_obstructive.pdf
Accepted Author Manuscript
License: Unspecified
Download (386kB)| Preview

Abstract

The benefits of inspiratory muscle strength training in decreasing symptoms, disability or handicap of patients affected by COPD are not well established. The objective of this study was to assess the efficacy of the constant use of a new flow-volumetric inspiratory exerciser, named Respivol™, in improving respiratory functional parameters in COPD patients. Twenty consecutive ambulatory patients affected by COPD were enrolled. Each patient was assessed, before and after 3 and 6 months inspiratory exercise with Respivol™, for the following clinical parameters: maximal inspiratory pressure, maximal expiratory pressure, dyspnoea grade, quality of life by a self-administered St George questionnaire and a 6-min walking test. After a brief progressive ambulatory training programme, inspiratory exercise with Respivol™ was performed at home for 6 months. All patients used Respivol™ together with medical treatment. Maximal inspiratory pressure and maximal expiratory pressure values were significantly increased after 3 and 6 months of exercise. Dyspnoea grade was significantly reduced and the 6-min walking test showed an increase in effort tolerance, after 6 months of home training. Quality of life assessment showed an improvement, associated with a decrease of respiratory disease symptoms. Inspiratory muscle strength training with Respivol™ seems to be efficient in reducing symptoms and improving quality of life in adults with COPD.

CORE (COnnecting REpositories)